Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
EBITDA Margin
14.98%
TTM · Period ending:
TEVA EBITDA Margin
Latest reported14.98%period ending
Latest reported14.98%period ending
TEVA TTM EBITDA Margin (23.23% → 14.98%)
TTM ebitda margin
High-resolution chart · PNG
TEVA ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 14.9821% | |
| 18.8494% | |
| 19.3881% | |
| 23.1044% | |
| 17.9166% | |
| 15.4559% | |
| 10.0949% | |
| 12.0744% | |
| 15.0092% | |
| 19.8013% | |
| 24.7192% | |
| 11.8779% | |
| 12.8255% | |
| 13.1658% | |
| 5.3132% | |
| 10.6327% | |
| 12.3753% | |
| 11.5632% | |
| 18.7543% | |
| 23.8048% | |
| -6.9595% | |
| -9.0892% | |
| -10.2053% | |
| -10.2027% | |
| 15.2848% | |
| 10.5825% | |
| 10.5454% | |
| -11.5325% | |
| -6.9244% | |
| -3.1409% | |
| 4.7046% | |
| -45.3832% | |
| -41.6079% | |
| -65.5225% | |
| -66.8037% | |
| -10.5688% | |
| -10.8981% | |
| 14.4655% | |
| 15.4408% | |
| 24.2953% | |
| 26.6878% | |
| 31.8018% | |
| 29.5593% | |
| 28.3866% | |
| 27.2777% | |
| 25.4481% | |
| 26.8646% | |
| 24.6372% | |
| 24.4315% | |
| 17.3019% | |
| 17.2295% | |
| 16.2966% | |
| 10.9847% | |
| 18.786% | |
| 19.1072% | |
| 19.919% | |
| 25.164% | |
| 17.058% | |
| 16.2953% | |
| 17.9782% | |
| 19.0507% | |
| 29.6833% | |
| 30.0726% | |
| 27.5008% | |
| 25.8291% | |
| 24.1236% | |
| 22.4117% | |
| 15.226% | |
| 14.2273% | |
| 13.2247% | |
| 14.7767% | |
| 29.0669% | |
| 30.2893% | |
| 31.697% | |
| 30.9949% | |
| 29.0008% | |
| 30.0196% | |
| 31.1792% | |
| 30.4305% | |
| 32.4586% | |
| 29.302% | |
| 25.3943% | |
| 27.0465% | |
| 25.958% | |
| 26.4219% | |
| 26.46% | |
| 37.5294% | |
| 40.1145% | |
| 41.4646% | |
| 45.8224% | |
| 29.4531% | |
| 27.0856% | |
| 26.1827% | |
| 21.7914% | |
| 20.8052% | |
| 20.2244% | |
| 20.3523% | |
| 19.7489% | |
| 18.8536% | |
| 21.7237% |